Bio-Path Holdings Inc. (NASDAQ:BPTH) Q4 2021 Earnings Conference Call March 11, 2022 8:30 AM ET Company Participants Will O’Connor - Investor Relations, Stern Peter Nielsen - Chief Executive Officer Anthony Price - SVP, Finance, Accounting & Administration Conference Call Participants Yi Chen - HC Wainwright Operator Good morning, ladies and gentlemen. Welcome to the Bio-Path Holdings Full Year 2021 Earnings Conference Call. At this time, all participants are in a listen-only mode. Following the formal rema ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-36333 BIO-PATH HOLDINGS, INC. (Exact name of registrant as specified in its charter) | --- | --- | |--------------- ...

Bio-Path Holdings, Inc. (NASDAQ:BPTH) Q3 2021 Earnings Conference Call November 12, 2021 8:30 AM ET Company Participants Will O'Connor - Stern IR Peter Nielsen - President, CEO and CFO Anthony Price - SVP of Finance, Accounting and Administration Conference Call Participants Laura Engel - Stonegate Capital Partners Jonathan Aschoff - ROTH Capital Partners Yi Chen - H.C. Wainwright Operator Good morning, ladies and gentlemen, and welcome to the Bio-Path Holdings Third Quarter 2021 Earnings Conference Call. [ ...

Table of Contents Delaware 87-0652870 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 4710 Bellaire Boulevard, Suite 210, Bellaire, Texas 77401 (Address of principal executive offices) (Zip Code) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 Or ☐ TRANSITION REPORT PURSUANT ...

Bio-Path Holdings, Inc. (NASDAQ:BPTH) Q2 2021 Earnings Conference Call August 13, 2021 8:30 AM ET Company Participants Peter Nielsen - President, CEO and CFO Anthony Price - SVP of Finance, Accounting and Administration Will O’Connor - Stern IR Conference Call Participants Yi Chen - H.C. Wainwright Laura Engel - Stonegate Capital Partners Operator Good morning, ladies and gentlemen and welcome to the Bio-Path Holdings' Second Quarter 2021 Earnings Conference Call. At this time, all participants are in a lis ...

Table of Contents Delaware 87-0652870 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 4710 Bellaire Boulevard, Suite 210, Bellaire, Texas 77401 (Address of principal executive offices) (Zip Code) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 Or ☐ TRANSITION REPORT PURSUANT TO S ...

Bio-Path Holdings, Inc. (NASDAQ:BPTH) Q1 2021 Earnings Conference Call May 14, 2021 8:30 AM ET Company Participants Peter Nielsen - President, CEO and CFO Anthony Price - SVP of Finance, Accounting and Administration Will O’Connor - Stern IR Conference Call Participants Jonathan Aschoff - ROTH Capital Partners Yi Chen - H.C. Wainwright Operator Good morning, ladies and gentlemen. Welcome to the Bio-Path Holdings' First Quarter 2021 Earnings Conference Call. At this time, all participants are in a listen-onl ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 Or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __ to __ Commission file number: 001-36333 Bio-Path Holdings, Inc. (Exact name of registrant as specified in its charter) | --- | --- | --- | |--------------- ...

Bio-Path Holdings, Inc (NASDAQ:BPTH) Q4 2020 Earnings Conference Call March 10, 2021 8:30 AM ET Company Participants Will O'Connor - Stern IR Peter Nielsen - President and CEO Anthony Price - SVP of Finance, Accounting, and Administration Conference Call Participants Yi Chen - H.C. Wainwright Jonathan Aschoff - ROTH Capital Partners Laura Engle - Stonegate Capital Partners Operator Good morning, ladies and gentlemen. Welcome to the Bio-Path Holdings' Full-Year 2020 Earnings Conference Call. At this time, al ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Delaware 87-0652870 (State or other jurisdiction of incorporation (I.R.S. Employer Identification No.) or organization) 4710 Bellaire Boulevard, Suite 210, Bellaire, Texas 77401 (Address of principal executive offices) (Zip Code) Title of each class Trading Symbol Name of each exchange on which registered Common Stock, par value $0.001 per share BPTH The Nasdaq Capital Market FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 O ...